Skip to content

Establishment of precise diagnosis and treatment system for Intractable fundus disease

Establishment of precise diagnosis and treatment system for Intractable fundus disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036665
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fundus disease

Interventions

Gold Standard:Metagenomic sequencing or pathogen detection.
diagnosis&#32
and&#32
system&#32
for&#32
Intractable&#32

Sponsors

Eye and ENT hospital of FuDan university
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Suspected potential patients with single gene mutation inherited eye disease or patients with ocular fundus disease with poor diagnostic/therapeutic efficacy. 2. Informed consent of participants. 3. Available DNA sample or intraocular fluid sample. 4. Patients present with a definite inherited disease, and the genetic diagnosis may significantly alter clinical treatment. Phenotypes or family history are closely related to the genetic etiology. 5. The patient is unlikely to die soon.

Exclusion criteria

Exclusion criteria: 1. Common fundus oculi diseases with clear diagnosis and good prognosis; 2. Patients without fundus oculi disease; 3. For patients with difficult ocular fundus disease, blood sample extraction or intraocular fluid extraction cannot be performed due to special reasons.

Design outcomes

Primary

MeasureTime frame
genetic mutation;

Secondary

MeasureTime frame
Etiological data;

Countries

China

Contacts

Public ContactXu Gezhi

Eye and ENT Hospital of Fudan University

drxugezhi@163.com+86 18017316316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026